Outcomes of stereotactic body radiotherapy (SBRT) in 175 patients with stage I NSCLC aged 75 years and older

被引:0
|
作者
Senan, S. [1 ]
Haasbeek, C. J. [1 ]
Antonisse, M. E. [1 ]
Slotman, B. J. [1 ]
Lagerwaard, F. J. [1 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9545
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Adaptive Strategies to Reduce Toxicity of Stereotactic Body Radiotherapy (SBRT) for Large Stage I Lung Tumors
    Dahele, M.
    de Koste, J. R. van Sornsen
    Slotman, B.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S527 - S527
  • [42] Safety and efficacy of stereotactic body radiotherapy in patients with early stage NSCLC: systematic review
    Sabran, Mohammad Z.
    Sukendro, Gavin M.
    Yogobi, Yalimo P.
    Kogoya, Austa M.
    Hamdoyo, Audrey
    Law, Natasha K.
    Kurniawan, Andree
    ANNALS OF ONCOLOGY, 2022, 33 : S536 - S536
  • [43] STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN OLIGOMETASTATIC PATIENTS WITH CANCER OF THE PROSTATE
    Bortolato, Barbara
    Bracco, Francesco
    Sibio, Daniela
    Carbonini, Claudia
    Brambilla, Maria Grazia
    Palazzi, Mauro Filippo
    ANTICANCER RESEARCH, 2019, 39 (03) : 1514 - 1514
  • [44] Stereotactic Body Radiotherapy (SBRT) in oligometastatic prostate cancer patients
    Chaw, C. L.
    Henderson, D.
    Khoo, V.
    Tree, A.
    Eeles, R.
    Van As, N.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S209 - S209
  • [45] Stereotactic body radiotherapy (SBRT) for oligometastatic prostate cancer patients
    Kalinauskaite, G.
    Stromberger, C.
    Tinhofer, I
    Kufeld, M.
    Senger, C.
    Budach, V
    Gruen, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S153 - S154
  • [46] ROLE OF STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) IN STAGE I NSCLC
    Slotman, Ben
    Lagerwaard, Frank
    Haasbeek, Niels
    Verstegen, Naomi
    Dahele, Max
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S103 - S103
  • [47] Correction to: Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early‑stage non‑small cell lung cancer
    Zekai Shu
    Baiqiang Dong
    Lei Shi
    Wei Shen
    Qingqing Hang
    Jin Wang
    Yuanyuan Chen
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 3139 - 3139
  • [48] Stereotactic Body Radiotherapy for Stage I NSCLC The Challenge of Evidence-Based Medicine Reply
    Guckenberger, Matthias
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (02) : E17 - E18
  • [49] Modelling of pulmonary function test changes after stereotactic body radiotherapy for stage I NSCLC
    Roesch, J.
    Stam, B.
    Belderbos, J.
    Peulen, H.
    Flentje, M.
    Giuliani, M.
    Hope, A.
    Werner-Wasiks, M.
    Hong, Y.
    Grills, I.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S100 - S100
  • [50] PRELIMINARY RESULTS OF THE FIRST 26 PATIENTS TREATED WITH STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR STAGE I-II LUNG CANCER
    Dieleman, Edith
    Uitterhoeve, Lon
    Kamphuis, Martijn
    Gangel, Pieter
    Van Os, Rob
    Koedooder, C.
    Van Wieringen, Niek
    Koning, Caro
    Wendling, Markus
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S831 - S832